Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Daiichi Sankyo
Novartis
Mallinckrodt
Covington
Harvard Business School
Baxter
Citi
UBS

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,198,226

« Back to Dashboard

Summary for Patent: 5,198,226
Title: Long acting nicardipine hydrochloride formulation
Abstract:A long acting sustained release pharmaceutical composition for dihydropyridine calcium channel blockers wherein the calcium channel blocker and a pH-dependent binder are intimately admixed in essentially spherically shaped non-rugose particles of up to 1.2 mm in diameter.
Inventor(s): MacFarlane; Calum B. (Linlitchgow, GB6), Selkirk; Alastair B. (Edinburgh, GB6), Dey; Michael J. (East Calder, GB6)
Assignee: Syntex (U.S.A.) Inc. (Palo Alto, CA)
Application Number:07/794,356
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Drugs Protected by US Patent 5,198,226

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,198,226

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 81973 ➤ Subscribe
Australia 604672 ➤ Subscribe
Australia 6810287 ➤ Subscribe
Canada 1285227 ➤ Subscribe
Germany 3782439 ➤ Subscribe
Denmark 175216 ➤ Subscribe
Denmark 47787 ➤ Subscribe
European Patent Office 0231026 ➤ Subscribe
European Patent Office 0301133 ➤ Subscribe
Spain 2052500 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
US Army
Baxter
Medtronic
Chubb
Mallinckrodt
Dow
Federal Trade Commission
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot